Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome

per Davies, Helen R., Hodgson, Kirsty, Schwalbe, Edward, Coxhead, Jonathan, Sinclair, Naomi, Zou, Xueqing, Cockell, Simon, Husain, Akhtar, Nik-Zainal, Serena, Rajan, Neil
Publicat a Nat Commun (2019)

Overexpression of MYB drives proliferation of CYLD‐defective cylindroma cells

per Rajan, Neil, Andersson, Mattias K, Sinclair, Naomi, Fehr, André, Hodgson, Kirsty, Lord, Christopher J, Kazakov, Dmitry V, Vanecek, Tomas, Ashworth, Alan, Stenman, Göran
Publicat a J Pathol (2016)

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial

per Danilenko, Marina, Stamp, Elaine, Stocken, Deborah D., Husain, Akhtar, Zangarini, Monique, Cranston, Amy, Stones, Robert, Sinclair, Naomi, Hodgson, Kirsty, Bowett, Susan A., Roblin, David, Traversa, Silvio, Plummer, Ruth, Veal, Gareth, Langtry, James A. A., Ashworth, Alan, Burn, John, Rajan, Neil
Publicat a JAMA Dermatol (2018)